Novati Announces Launch of Nanofabrication Services and Manufacturing Site

Novati Technologies announced today the launch of its nanofabrication services and manufacturing site, featuring the world’s broadest portfolio of product-development capabilities and materials. The newly named company builds on 25 years of technology leadership cultivated from its roots at SEMATECH and, most recently, the SVTC fabrication foundry.

Aiming for a leadership role in nanofabrication capabilities for the More-than-Moore markets, Novati President Dave Anderson has assembled the world's largest portfolio of product development materials. (Photo: Business Wire)

Citing an acute need for leadership in the rapid evolution of technologies away from the historic guidance of Moore’s Law and toward a larger set of emerging opportunities, Novati’s team of expertise and assets has been assembled to provide the leading edge for an effort aimed at creation of new markets that don't depend on the smallest feature sizes but rather on driving new combinations of materials for products. This drive to incorporate new functionalities for devices that don’t necessarily need to scale is regarded as ‘More-than-Moore.’

Offering a significant advantage over traditional foundries that typically limit customers to working with no more than 25 elements from the periodic table, Novati’s unique position engages a world-leading 60 elements in order to move exotic ideas and breakthrough designs into development and production. Large corporations, small startup ventures and university spin-offs alike report they will use Novati because other venues are simply not able to meet the needs of the most rapid product development criteria.

"We rely on the portfolio of development materials that Novati offers and their comprehensive suite of advanced tools as a critical piece of our equation for going to market," said Randy Goodall, CEO of NanoMedical Systems. "Novati turns our great ideas into reliable, manufacturable technologies that give the world the next game-changing medical products. The nanofluidic chips that Novati fabricates for our drug delivery implants are the first and only ones ever made with long-term Angstrom-level structural stability while inside the body."

Examples of other global advancements created with Novati’s novel portfolio and development process are found in the Life Sciences sector, where Novati built a DNA sequencing device that enabled end customers to resolve a mysterious and deadly E. coli outbreak. In a consumer Telecom application, Novati has developed new micro electro mechanical systems (MEMS) technology for an elastic autofocus/autozoom lens for cell phone cameras. In Security, Novati has quadrupled the technology roadmap for complex night vision sensors.

“No longer dependent on shrinkage of features, today’s rapidly emerging nano-electronic products are driven by heterogeneous integration of multiple technologies and novel materials. That’s where Novati excels,” said Dave Anderson, president of the newly formed Novati Technologies. “Offering unrivaled speed, we’re spearheading the implementation of never-before-used materials and new processing methods that lead to breakthroughs in device design and drive the revolution for today’s ‘More-than-Moore’ markets.”

Formed following an unexpected closure of SVTC’s foundry centers in 2012, Novati teams with its customers to leap beyond previous constraints in the services offered by its former SVTC owner. Novati is an early adopter of carbon nanotubes (CNTs) and has demonstrated integration of magnetic, phase-change materials and is a pioneer in the integration of superconducting materials and heterogeneous integration of III-V materials on silicon.

Novati staff will participate in the SEMICON West global semiconductor industry conference, to be held July 9-11 in San Francisco, to discuss their nanofabrication services and products with representatives from a wide range of emerging markets.

Press release avilable from http://www.businesswire.com/

Source: http://www.novati-tech.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.